Skip to content

    Fairchem Organics Q1 FY27 earnings call

    FAIRCHEMOR
    Chemicals·28 Jul 2026
    Management Summary

    Fairchem Organics reported a strong Q1 FY27 with revenue growing 34.4% YoY to ₹176 crores and EBITDA margin improving to 10.14%. This growth was primarily driven by higher price realization and reduced imports. The company is focused on increasing capacity utilization from the current 60% to 70-75% by year-end and plans to introduce a new product next quarter. Key challenges include the inverted duty structure and the persistent risk of China dumping.

    Highlights

    5
    • Revenue from operations increased by 34.4% YoY to ₹176 crores, driven by higher price realization and lower imports.

    • EBITDA margin improved to 10.14% (₹18 crores EBITDA) due to better realization in domestic markets and eased import pressure.

    • Net profit for the quarter was ₹10 crores.

    • Successful energy conservation initiatives led to over 30% reduction in power consumption and over 35% in solid fuel consumption.

    • A new raw material product, developed in-house, is slated for introduction next quarter.

    Concerns

    4
    • The inverted duty structure (16.5% on raw material vs. 7.5% on finished product) results in a 9% margin loss.

    • Risk of China dumping impacting margins if supply chain constraints ease, as acknowledged by management.

    • Ramp-up of Isostearic acid is slow due to stringent entry barriers and few buyers in the cosmetics industry.

    • Management is unwilling to enter long-term contracts due to high market volatility.

    Key financials

    Single quarter

    06 metrics
    1. 01Revenue from Operations₹176 Cr+34.4%YoY
    2. 02EBITDA₹18 Cr
    3. 03EBITDA Margin10.1%
    4. 04Net Profit₹10 Cr
    5. 05Raw Material Processed12,400 tonnes

    Segment breakdown

    Dimer Acid
    30% Revenue Share
    Linoleic Acid
    42% Revenue Share
    Isostearic Acid
    4% Revenue Share
    Other By-products
    24% Revenue Share
    List

    Capital allocation

    1
    low confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Guidance & targets

    6
    CategoryTargetPriority
    Profitability
    Revenue and Margin Run Rate
    Maintain similar run rate
    Medium
    Capacity
    Isostearic Acid Capacity Utilization
    More than 80% utilization
    Medium
    Capacity
    Overall Capacity Utilization
    70-75%
    Medium
    Capacity
    Capacity Utilization Increase
    15-20% by end of FY27
    Medium
    New Product
    New Raw Material Introduction
    One new raw material
    High
    Volume
    Sales Volume Growth
    5-7% quarterly growth
    Medium

    What to watch in Q2 FY27

    4

    New Raw Material Product Introduction

    Next quarter
    CurrentPlanned for next quarter
    TargetSuccessful introduction and trial run stabilization

    Why it matters

    Indicates progress on R&D and diversification into new products, potentially with better margins.

    Next quarter, we will be introducing one new raw material.

    Risks & concerns

    4
    RiskSeverity

    Inverted Duty Structure

    Raw material import duty (16.5%) is higher than finished product duty (7.5%), leading to a 9% margin loss.Management acknowledged

    high

    China Dumping

    If China resumes dumping, it could negatively impact margins, a risk beyond the company's control.Management acknowledged

    medium

    Slow Isostearic Acid Ramp-up

    Ramp-up for Isostearic acid is taking longer than expected due to stringent entry barriers and limited buyers in the cosmetics industry.Management acknowledged

    medium

    Market Volatility

    High market volatility makes management unwilling to enter long-term supply contracts, preferring spot market dynamics.Management acknowledged

    medium

    Q&A highlights

    8

    “It's around 50 lakhs is only spent on the revenue side. The salary and the capital expenditure is on need-based basis. So, it is 1-1.5% as of now.”

    Analyst questioned the lack of gross margin improvement despite R&D, management clarified R&D spend and attributed margin issues to inverted duty structure.

    asked by Sajal Kapoor

    2 min read6 chapters

    Detailed Narrative

    01

    Q1 FY27 Financial Performance Overview

    Fairchem Organics reported a robust Q1 FY27, with revenue from operations reaching ₹176 crores, marking a significant 34.4% year-on-year increase. The company achieved an EBITDA of ₹18 crores, translating to an EBITDA margin of 10.14%. Net profit for the quarter stood at ₹10 crores. During the period, the company processed 12,400 tonnes of raw material and sold 13,500 tonnes of finished products.

    02

    Operational Highlights and Margin Improvement Drivers

    The improved financial performance was primarily driven by higher price realization, attributed to elevated raw material costs and reduced imports amid ongoing supply chain constraints. Management noted that EBITDA margins improved to over 10% due to better realization in domestic markets as import pressure eased. The company also undertook major energy conservation exercises, reducing power consumption by over 30% and solid fuel consumption by over 35%.

    03

    Product Mix and R&D Initiatives

    The revenue mix for Q1 FY27 comprised 30% from dimer acid, 42% from linoleic acid, 4% from Isostearic acid, and 24% from other by-products. The company's R&D efforts include continuous time and motion studies to optimize manpower and working on new catalysts to reduce consumption and improve value. A new raw material product, developed through in-house R&D, is scheduled for introduction next quarter, falling within the oleochemical sector.

    04

    Capacity Utilization and Growth Outlook

    Current capacity utilization stands at approximately 60%. Management aims to increase this to 70-75% by the end of the financial year, targeting a 5-7% quarterly growth in quantity. The company expects to reach over 80% utilization for Isostearic acid within the next 1-2 years. Despite the slow ramp-up of Isostearic acid due to stringent entry barriers in cosmetics, management is actively working to secure approvals from buyers.

    05

    External Environment and Market Dynamics

    The company remains watchful of the evolving macroeconomic situation, including the Middle East crisis. However, the recently concluded India-UK Free Trade Agreement and the expected India-EU FTA are anticipated to strengthen export competitiveness. Reduced dumping from China and devaluation have also contributed to improved margins. Management noted that higher raw material costs were successfully passed on to consumers due to geopolitical supply chain issues and reduced imports.

    06

    Challenges and Risks

    A significant challenge is the inverted duty structure, where raw materials are charged 16.5% duty while finished products face 7.5%, resulting in a 9% margin loss. The risk of China dumping remains a concern if supply chain constraints ease, which management views as a business risk beyond their control. Due to high market volatility🌐, the company is hesitant to enter into long-term contracts, preferring to operate on a more flexible basis.

    This is an AI-generated summary of a publicly available earnings call transcript.